Myvac – Transgene

Transgene and NEC demonstrate high accuracy of AI-based neoantigen prediction for the design of individualized cancer vaccine TG4050

20200515_AACR myvac curtain raiser EN

By nh|2020-05-14T17:13:26+02:00May 15th, 2020|Myvac, Press release, TG4050|Comments Off

20190916 PR ANSM TG4050 EN

By nh|2020-04-23T15:54:37+02:00September 16th, 2019|Myvac, Press release, TG4050|Comments Off

20190710 PR MHRA TG4050 EN

By nh|2020-04-23T15:54:47+02:00July 10th, 2019|Myvac, Press release, TG4050|Comments Off

20190513 PR IND TG4050 EN

By alcyon|2020-04-23T15:54:54+02:00May 13th, 2019|Myvac, Press release, TG4050|Comments Off

20190305-PR-NEC-Agreement-US-1

By Lucie Larguier|2020-04-23T15:55:24+02:00March 5th, 2019|Myvac, Press release, TG4050|Comments Off

Christian Ottensmeier, et al. SITC 2018, November 2018 - Abstract [...]

By alcyon|2019-07-01T15:07:38+02:00November 7th, 2018|Myvac, Publication|Comments Off

20181107 SITC Poster EN

By alcyon|2020-04-03T08:29:57+02:00November 7th, 2018|Invir.IO, Myvac, Press release|Comments Off

Press Release NEC- Transgene EN

By alcyon|2019-06-03T19:46:51+02:00October 30th, 2018|Myvac, Press release|Comments Off

20181001 SITC Poster VEN

By alcyon|2019-06-03T19:46:22+02:00October 2nd, 2018|Invir.IO, Myvac, Press release|Comments Off

20180924 MyVac EN

By alcyon|2019-06-05T16:49:54+02:00September 24th, 2018|Myvac, Press release|Comments Off